Supernus Pharmaceuticals Inc (SUPN)
Inventory turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cost of revenue | US$ in thousands | 0 | 467,442 | 382,420 | 257,436 | 176,585 |
| Inventory | US$ in thousands | 77,408 | 91,541 | 85,959 | 48,325 | 26,628 |
| Inventory turnover | 0.00 | 5.11 | 4.45 | 5.33 | 6.63 |
December 31, 2023 calculation
Inventory turnover = Cost of revenue ÷ Inventory
= $0K ÷ $77,408K
= 0.00
Supernus Pharmaceuticals Inc's inventory turnover has fluctuated over the past five years, ranging from 0.63 in 2019 to 1.09 in 2020. The inventory turnover ratio indicates the number of times a company sells and replaces its inventory during a period. A higher inventory turnover ratio typically suggests that the company is effectively managing its inventory levels and selling products efficiently. On the other hand, a lower ratio may indicate overstocking, obsolete inventory, or inefficiencies in the sales process.
In Supernus Pharmaceuticals Inc's case, the inventory turnover ratio has generally been relatively low, with the highest value in 2020 at 1.09 and the lowest in 2019 at 0.63. This suggests that the company may have experienced challenges in optimizing its inventory management and sales processes during these years. It would be beneficial for the company to further analyze the reasons behind these fluctuations and take appropriate actions to improve inventory turnover efficiency in the future.
Peer comparison
Dec 31, 2023